Zachary Quinn Beck

This inventor holds 22 USPTO granted patents and 6 published patent applications and 5 EPO patents, primarily in Isoprene Production. Top assignees: Danisco US Inc., The Goodyear & Tire Rubber Company, Other. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zachary Quinn Beck. Retrieved from https://idiyas.com/inventor/zachary-quinn-beck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 6)

% Patents Active = 54.5

EPO Patents = 5 (Patent Applications = 17)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 63(Granted Patents)

Company Filing History:

The Goodyear & Tire Rubber Company

patents

1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2022

Loading Chart...

Areas of Expertise:

Isoprene

Phosphoketolase

Mevalonate

Recombinant Microorganisms

Isoprene Synthase

Enzymatic Activities

Isoprenoid Precursors

PGL Compositions

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11371035 - Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoid (2022-06-28),

2. 10988750 - Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids (2021-04-27),

3. 10975394 - Recombinant microorganisms for enhanced production of mevalonate, isoprene, and isoprenoids (2021-04-13),

4. 10364443 - Production of mevalonate, isoprene, and isoprenoids using genes encoding polypeptides having thiolase, HMG-CoA synthase and HMG-CoA reductase enzymatic activities (2019-07-30),

5. 10246694 - Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids (2019-04-02),

6. 10138498 - Recombinant microorganisms for enhanced production of mevalonate, isoprene, and isoprenoids (2018-11-27),

7. 10113185 - Utilization of phosphoketolase in the production of mevalonate, isoprenoid precursors, and isoprene (2018-10-30),

8. 9752162 - Production of mevalonate, isoprene, and isoprenoids using genes encoding polypeptides having thiolase, HMG-CoA synthase and HMG-CoA reductase enzymatic activities (2017-09-05),

9. 9493791 - Utilization of phosphoketolase in the production of mevalonate, isoprenoid precursors, and isoprene (2016-11-15),

10. 9464301 - Increased isoprene production using the archaeal lower mevalonate pathway (2016-10-11),

11. 9353375 - Compositions and methods of PGL for the increased production of isoprene (2016-05-31),

12. 9273298 - Isoprene synthase variants for improved production of isoprene (2016-03-01),

13. 9175313 - Three-dimensional structure of isoprene synthase and its use thereof for generating variants (2015-11-03),

14. 9163263 - Identification of isoprene synthase variants with improved properties for the production of isoprene (2015-10-20),

15. 9121038 - Recombinant microorganisms for enhanced production of mevalonate, isoprene, and isoprenoids (2015-09-01),

Title: **Zachary Quinn Beck: Innovator in Acetyl Coenzyme A-Derived Metabolites**

Introduction

Zachary Quinn Beck, located in Palo Alto, CA, is a prominent inventor with an impressive portfolio of 22 patents. His innovative work primarily focuses on biotechnological processes, particularly in the production of valuable metabolites.

Latest Patents

Among his latest contributions to the field is the patent for "Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids." This invention involves cultured recombinant cells that incorporate heterologous phosphoketolase (PKL) polypeptides. These cells are designed to enhance the production of acetyl coenzyme A-derived metabolites. Additionally, in certain embodiments, these recombinant cells include mevalonate (MVA) pathway polypeptides, further facilitating the production of isoprenoid precursors, isoprene, and various isoprenoids.

Career Highlights

Zachary has made significant strides in his career, working with established companies such as Danisco US Inc. and The Goodyear Tire & Rubber Company. His contributions in these roles have played a crucial part in advancing the fields of biotechnology and synthetic biology.

Collaborations

Throughout his career, Zachary has collaborated with notable professionals, including Derek H. Wells and Caroline M. Peres. These partnerships have bolstered his research and innovation efforts, leading to groundbreaking advancements in metabolite production.

Conclusion

Zachary Quinn Beck continues to push the boundaries of innovation in biotechnological processes. His research and patents reflect a commitment to improving production methods for valuable metabolites, showcasing his role as a leading inventor in the industry. His contributions not only enhance the field of biotechnology but also present opportunities for sustainable production methods in various applications.

Profile summary based on public USPTO records.